Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $90

Benzinga Newsdesk www.benzinga.com Neutral 47.7%

Neg 0% Neu 47.7% Pos 0%

Canaccord Genuity analyst Jon Young maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $99 to $90.